Riina Kuuselo

MED29 Possesses a Complex Role in Pancreatic Cancer

Riina Kuuselo, 2010 .

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.

S. Mousses, A. Kallioniemi, D. Azorsa, 2007, Cancer research.

MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer

A. Kallioniemi, R. Autio, K. Savinainen, 2011, International journal of cancer.

19q13 amplification is associated with high grade and stage in pancreatic cancer

G. Sauter, A. Marx, A. Kallioniemi, 2010, Genes, chromosomes & cancer.

Characterization of the 7q21‐q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer

A. Kallioniemi, R. Karhu, Eeva Laurila, 2009, Genes, chromosomes & cancer.

Characterization of the 7q21‐q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer

A. Kallioniemi, R. Karhu, Eeva Laurila, 2009, Genes, chromosomes & cancer.